750 new cancer drugs

Pharmaceutical Company and Industry Association of American researchers, including 750 against tumor 240'ı working on new cancer drug is announced


Researchers Association of Pharmaceutical Companies (AİFD), American Pharmaceutical Company and Industry Research Association (PhRMA) reports issued by 750 different drugs for different cancer types was working on was being announced. In the report, the majority of new drug studies are currently under clinical investigation were also expressed.

S new drug available to patients with cancer less deadly, and a manageable disease like diabetes has a significant distance in the direction will be recorded in the report emphasized, the studies with significant economic benefits to be provided was also expressed. The annual cost of cancer in the United States reached 219.2 billion dollars was mentioned, the treatment costs with this amount, because of illness and death caused by the cost of lost labor force was reported to take place. Different types of cancer every year AİFD more than 100 thousand people lost their lives to cancer in Turkey, which led most to death is to be the second disease is reported.

There are 204 new drug candidates against Tumors
PhRMA'nın published report, the efforts to eliminate tumors effectively and to enhance the effect of chemotherapy that is being expressed, in tumors of 204 new drugs under development to the island where it was stated. The report also 122 against leukemia, lung cancer against the 110, against breast cancer 90, prostate cancer and 88 from lymph cancer for 86 new drug candidate, is working on, especially the brain, skin, stomach, intestine and liver to be many different types of cancer research from The time was also reported.

"We are working on innovative medicines to reach lara"
Engin Güner AİFD Secretary General, in the field of cancer research in regards to that "Today, the fear of the cancer diagnosis," he said. The world millions of people each year lose their lives that brought a variety of diseases from cancer Güner, researchers, pharmaceutical companies and develops innovative medicines biyogenetik also give hope that in this area expressed ların the Güner, said:
"Cancer is obtained against the continuous new achievements. The new drug candidates currently under development is also offered to patients, cancer or heart disease just like diabetes, a disease can be managed to become important in the direction of distance will be recorded. S innovative medicines save lives, and improve the quality of life and to create value for society.

Important as the necessary treatment, access to innovative medicines to make timely lara. Americans and Europeans of Turkish patients or patients with innovative drugs is no access at the same time we should aim to provide. Ministry of Health and the sector as AİFD especially müzdeki in compliance with other institutions, sometimes 2 - 3 years, extended up to continue to work on innovative medicines to no access. "